MYD88 and neoplasm: Interestingly, we found that MYD88 expression levels were significantly elevated in subtype C1 (p < 0.05; Supplementary Figure S7), and thus, we believe that MYD88L265P might contribute to the activation of the TLR signalling pathway in subtype C1 and induce tumour development.